These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6684989)

  • 1. Combined chemotherapy with ifosfamide and cisplatin and with ifosfamide and etoposide (VP-16) in non-small cell carcinoma of the bronchus.
    Manke HG; Drings P; Stiefel P; Schmitteckert H; Grimm V; Kleckow M
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():125-8. PubMed ID: 6684989
    [No Abstract]   [Full Text] [Related]  

  • 2. Etoposide and ifosfamide in combination for inoperable carcinoma of the bronchus.
    Schilcher RB; Seeber S; Scheulen ME; Schmidt CG
    Cancer Treat Rev; 1982 Jun; 9 Suppl():107-10. PubMed ID: 7127333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ifosfamide and adriamycin after induction with cisplatin and etoposide (VP-16) in pulmonary microcytoma. Preliminary results].
    Antilli A; Cruciani AR; Nunziati F; Orazi D; Portalone L; Signora M; Salvati F
    G Ital Chemioter; 1985; 32(1):71-2. PubMed ID: 3007254
    [No Abstract]   [Full Text] [Related]  

  • 4. Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
    Kredentser DC
    Gynecol Oncol; 1991 Nov; 43(2):145-8. PubMed ID: 1743556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage chemotherapy for lymphoma with VP-16, ifosfamide, and cisplatin.
    Nichols CR; Loehrer PJ; Greist A; Kubilis PS; Hoffman R
    Med Pediatr Oncol; 1988; 16(1):12-6. PubMed ID: 3340061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Ardizzoni A; Fusco V; Gulisano M; Pronzato P; Baracco F; Capaccio A; Pastorino G; Nosenzo M; Felletti R; Fabiano F
    Cancer Treat Rep; 1987 Dec; 71(12):1311-2. PubMed ID: 2825994
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK; Stewart D; Logan D; Maroun J; Goss G; Shepherd FA; Latreille J; Warner E; Dahrouge S
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Drings P; Manke HG
    Strahlentherapie; 1985 Mar; 161(3):131-3. PubMed ID: 2983459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide (with mesna), vincristine and cis-platinum for carcinoma of the head and neck.
    Focan C; Le Hung S; Bays-Gallaix R; Frère MH; Demonceau G; Mbuyamba P; Salamon E; Claessens JJ
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():159-61. PubMed ID: 6684990
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
    Drings P; Abel U; Bülzebruck H; Stiefel P; Kleckow M; Manke HG
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S34-9. PubMed ID: 3028662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
    Paccagnella A; Favaretto A; Brandes A; Ghiotto C; Fornasiero A; Volpi A; Pappagallo G; Festi G; Cipriani A; Vinante O
    Cancer; 1990 Jun; 65(12):2631-4. PubMed ID: 2160312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
    Loehrer PJ; Ansari R; Gonin R; Monaco F; Fisher W; Sandler A; Einhorn LH
    J Clin Oncol; 1995 Oct; 13(10):2594-9. PubMed ID: 7595712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
    Faylona EA; Loehrer PJ; Ansari R; Sandler AB; Gonin R; Einhorn LH
    J Clin Oncol; 1995 May; 13(5):1209-14. PubMed ID: 7738623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide in small cell lung cancer.
    Einhorn LH
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma.
    Bidoli P; Spinazzè S; Santoro A; Casali P; Bedini AV; Guzzon A
    Am J Clin Oncol; 1990 Oct; 13(5):424-6. PubMed ID: 2171319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer.
    Pujol JL; Rossi JF; Le Chevalier T; Daurès JP; Rouanet P; Douillard JY; Dubois JB; Arriagada R; Mary H; Godard P
    Eur J Cancer; 1990; 26(7):798-801. PubMed ID: 2171600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapy.
    Scheulen ME; Bremer K; Niederle N; Seeber S
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():137-43. PubMed ID: 6627240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.